Adma Biologics reported $2.21B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Novavax USD 1.09B 316M Dec/2025
Takeda JPY 8.2T 809.7B Jun/2026